<?xml version="1.0" encoding="UTF-8"?>
<p id="Par5">As the pandemic ensues, we observe that children are affected less and most experience a mild form of the disease in case of infection [
 <xref ref-type="bibr" rid="CR4">4</xref>, 
 <xref ref-type="bibr" rid="CR23">23</xref>]. In the cohort study, including 72,314 COVID-19 patients, Wu et al. reported that only 2% of the cases were below 19Â years of age [
 <xref ref-type="bibr" rid="CR24">24</xref>]. We assume that the immunosuppressant patients constituted a primary risk group for COVID-19. However, the current data have not conferred immunosuppression as a specific risk factor for severe or fatal disease consistent with the epidemiologic data from the previous coronavirus epidemics, namely SARS and MERS (Middle East respiratory syndrome) [
 <xref ref-type="bibr" rid="CR25">25</xref>].
</p>
